Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q41719202)
Watch
English
Enzyme replacement therapy for Gaucher's disease
scientific article published on December 1997
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
review article
1 reference
stated in
Europe PubMed Central
title
Enzyme replacement therapy for Gaucher's disease
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
main subject
enzyme replacement therapy
0 references
Gaucher's disease
1 reference
based on heuristic
inferred from title
author name string
Beutler E
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
publication date
1 December 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
published in
Best Practice and Research: Clinical Haematology
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
volume
10
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
issue
4
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
page(s)
751-763
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
cites work
Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Economic malpractice in the treatment of Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment regimens in Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical course of treated and untreated Gaucher disease. A study of 45 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Sphingolipidoses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme Augmentation in Moderate to Life-Threatening Gaucher Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A less costly regimen of alglucerase to treat Gaucher's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of magnetic resonance imaging and ultrasound in evaluating liver size in Gaucher patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary hypertension in two patients with type I Gaucher disease while on alglucerase therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Individualised low-dose alglucerase therapy for type 1 Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose versus high-frequency regimens in Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ceredase dosing concerns for Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gaucher's Disease of the Lungs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glucocerebrosidase treatment of type I Gaucher disease with severe pulmonary involvement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replacement therapy with imiglucerase for type 1 Gaucher's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980038-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0950-3536(97)80038-8
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
Fatcat ID
release_nohsxxtgzvacnogrfloghvhh5e
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/nohsxxtgzvacnogrfloghvhh5e
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PubMed ID
9497862
1 reference
stated in
Europe PubMed Central
PubMed ID
9497862
retrieved
8 October 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit